Vital Specialized Biopharmaceutical Insights and Analytics

for Experts from Experts

BioTrends is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Featured Report
PatientTrends: Rheumatoid Arthritis US

Although there are many treatments available for RA, there is still a high unmet need for new treatments, especially for patients who are refractory to current therapies, such as TNF-alpha inhibitors, the most widely used biologic agents in RA.
Learn More

New Product 
ChartTrends: Chronic Kidney Disease: Non-Dialysis - Renal Anemia 2014 (China)

By comparing what nephrologists report about patient care dynamics to actual treatment records in CKD-ND, gaps in intended care versus actual care are uncovered and patient segments become more clearly defined. This new report covers patient demographics, referral patterns, length of treatment, blood transfusion rates, hospitalization rates and common reasons for referral in the Chinese market.
Learn More

Search Published Reports


See which reports have been searched on the most.


In the Spotlight

New Infographic

Download this new infographic on global biosimilars pathways and clinical development activity. Where are the biosimilars hotspots?



Recent Reports [ view all ]

  • Arthritic Pain - 2005

    Will emerging drugs replace the once-lucrative cyclooxygenase-2 (COX-2) inhibitors? Will any of the COX-2 inhibitors... Read More

  • Postoperative Pain - 2006

    Surprisingly, given the short treatment period for

    postoperative pain, drug sales in this market reached... Read More

  • Acute Myeloid Leukemia - 2006

    Acute myeloid leukemia (AML, also know as acute myelogenous
    leukemia) is largely a disease of adults, with the... Read More

Decision Resources Group brands include: